Cassava Sciences Inc vs NEOS S&P 500 High Income ETF — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while NEOS S&P 500 High Income ETF trades at $54.18. The key difference: NEOS S&P 500 High Income ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | SPYI | |
|---|---|---|
Market Cap | $47.75M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $4.64 | $54.19 |
52-Week Low | $0.87 | $47.98 |
Enterprise Value | -$34.93M | — |
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →